Parenteral amphotericin B: reminder of risk of potentially fatal adverse reaction if formulations confused

2018-07-17T14:36:28+01:00

Following receipt of a third case of fatal medication error caused by the administration of Fungizone (a non-lipid-based formulation of amphotericin B) instead of a lipid-based formulation (AmBisome, Abelcet), we remind healthcare professionals that these formulations are not interchangeable…